IGC Pharma, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
IGC Pharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2010 to Q3 2024.
  • IGC Pharma, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 76M shares, a 40% increase year-over-year.
  • IGC Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2016 was 25.7M shares, a 56.6% increase from 2015.
  • IGC Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2015 was 16.4M shares, a 11.1% increase from 2014.
  • IGC Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2014 was 14.8M shares, a 79.8% increase from 2013.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 76M +21.7M +40% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q3 2023 54.3M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q4 2017 28.2M +723K +2.64% Oct 1, 2017 Dec 31, 2017 10-Q 2018-02-20
Q3 2017 29.1M +5.42M +22.9% Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-17
Q2 2017 25.9M +2.55M +11% Apr 1, 2017 Jun 30, 2017 10-Q 2017-08-18
Q1 2017 25.7M +9.27M +56.6% Jan 1, 2017 Mar 31, 2017 10-K 2017-07-14
Q4 2016 27.4M +11.2M +69.2% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-20
Q3 2016 23.6M +8.64M +57.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-17
Q2 2016 23.3M +8.48M +57.2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-18
Q1 2016 16.4M +1.63M +11.1% Jan 1, 2016 Mar 31, 2016 10-K 2017-07-14
Q4 2015 16.2M +3.76M +30.2% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-21
Q3 2015 15M +2.77M +22.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-21
Q2 2015 14.8M +4.66M +45.8% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-16
Q1 2015 14.8M +6.55M +79.8% Jan 1, 2015 Mar 31, 2015 10-K 2016-07-14
Q4 2014 12.5M +4.73M +61.1% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-16
Q3 2014 12.2M +5.11M +71.8% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 10.2M +3.17M +45.3% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 8.21M +1.24M +17.8% Jan 1, 2014 Mar 31, 2014 10-K 2015-07-14
Q4 2013 7.73M +1.73M +28.8% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-12
Q3 2013 7.12M +1.11M +18.5% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 7M +3.1M +79.3% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 6.97M +4.06M +139% Jan 1, 2013 Mar 31, 2013 10-K 2014-07-15
Q4 2012 6.01M -15.3M -71.8% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-14
Q3 2012 6.01M -15M -71.3% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-08
Q2 2012 3.91M -16.5M -80.8% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-16
Q1 2012 2.91M Jan 1, 2012 Mar 31, 2012 10-K/A 2014-07-15
Q4 2011 21.3M Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-13
Q3 2011 21M +7.53M +56.1% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 20.4M +7.1M +53.6% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-08-21
Q3 2010 13.4M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-18
Q2 2010 13.3M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.